HIV protection with just two shots a year: FDA approves Gilead drug Lenacapavir, to be sold as Yeztugo, has potential to bring AIDS pandemic to heel but faces Trump-era obstacles Manage alerts for ...

On Thursday, the FDA approved lenacapavir, to be sold as Yeztugo, for the prevention of HIV in the U.S. The below essay, adapted from “Breakthrough: The Quest for Life-Changing Medicine” by ...

There's no question that HIV disproportionately impacts certain demographics in Fulton County. Statistics show that 85% of cases are men, with 15% women. Those numbers also show that 72% are Black ...